Full List Of Stories
Data on vaccine's ability to block Covid-19 transmission 'promising', Pfizer says
Data from animal trials on the ability of Pfizer and BioNTech's Covid-19 vaccine to block transmission of the novel coronavirus are "promising", the chairman of the former said.
Johnson and Johnson's Covid-19 vaccine generates 'promising' immune response
Johnson&Johnson's Covid-19 vaccine generated a 'promising' immune response, results from from phase one and two clinical trials showed.
Sector movers: Expectations for US stimulus feed gains in oil patch, weigh on Tech
Oil related stocks continued to find favour in the middle of the week as investors' focus shifted to the incoming US administration's augmented fiscal stimulus package that was due to be unveiled the next day.
Johnson and Johnson's Covid-19 vaccine approval possible in March
Emergency Use Approval for Johnson&Johnson's Covid-19 vaccine may not arrive before March, potentially a few weeks later than had been hoped for.
Thursday preview: US stimulus plans, Powell in focus
All eyes on Thursday will be fixated on the incoming US President's proposal for new government stimulus.
FTSE 250 movers: Credit Suisse upgrade drives gains for IMI, Howden Joinery lifts guidance
Engineering group IMI was near the top of the leaderboard on Wednesday, boosted by an upgrade out of Credit Suisse from 'neutral' to 'outperform'.
Europe close: Stocks edge higher on hopes for stimulus and vaccine roll-outs
European shares were slightly higher on Wednesday, with merger news involving French supermarket giant Carrefour countering negative sentiment around tightening Covid restrictions on the Continent and rapidly rising case counts in Spain and Ireland.
US CPI rises a bit more quickly than expected in December
The cost of living in the US rose a bit more quickly than expected at the end of 2020, mainly due to a jump in energy costs, although price pressures at the 'core' level remained subdued.
ECB's Lagarde slams lack of regulation on Bitcoin
The head of the European Central Bank called for global regulators to close off the 'loopholes' allowing Bitcoin to be used for 'funny business' such as money laundering.
Johnson & Johnson Covid vaccine trial results due soon, NYT says
Late stage clinical trial results for Johnson&Johnson's Covid-19 vaccine may be published in two weeks' time, possibly paving the way for the approval of another shot to combat the pandemic and further boosting supplies.